Clinical guidelines

The National Health and Medical Research Council (NHMRC) has endorsed two sets of clinical guidelines relevant for bowel cancer.

Page last updated: 17 November 2016

The guidelines provide practice points and recommendations for health professionals regarding cancer prevention, screening, diagnosis, treatment and management, and colonoscopy surveillance.

Revision of Clinical practice guidelines for the prevention, early detection and management of colorectal cancer (2005 edition)

Clinical Practice Guidelines for Surveillance Colonoscopy

Other guidelines, policies and evidence reviews

The Royal Australian College of General Practitioners’ Guidelines for preventive activities in general practice provides guidance on bowel cancer screening.

The Cancer Council Australia’s National Cancer Control Policy: Bowel Screening provides evidence on why the FOBT is the recommended screening tool for bowel cancer.

HealthPACT report - Blood and stool biomarker testing for colorectal cancer screening - August 2016 - an assessment which compared the FOBT used in the Australian NBCSP with other blood-based biomarker and stool-based tests for the detection of colorectal cancer. There is a lack of evidence to support the use of these tests to detect early adenomas.

In this section